论文部分内容阅读
用葡萄糖酸依诺沙星注射液治疗急性细菌感染性疾病１０５例，其中６７例与用头孢噻肟钠治疗的６３例进行随机对照试验，有效率及痊愈率各为９１．０４％、９５．２４％和７０．１５％、７７．７８％。细菌清除率各为８６．８％、９６．４％。副作用为８．９６％及１０．９４％。均无显著性差异。体外抗菌活性表明对革兰氏阳性及阴性细菌均具有较强的抗菌活性。１０５例用葡萄糖酸依诺沙星治疗急性细菌感染性疾病疗效显著，有效率９１．４％，痊愈率７２．３８％，细菌清除率为８８．３０％，副作用发生率８．３３％。对呼吸道、泌尿道感染及其他感染均取得良好的疗效。
105 cases of acute bacterial infectious diseases were treated with enrofloxacin gluconate injection, of which 67 cases were compared with 63 cases treated with cefotaxime sodium. The effective rate and cure rate were 91.04% and 95% respectively. 24% and 70.15%, 77.78%. Bacterial clearance rates were 86.8% and 96.4% respectively. Side effects were 8.96% and 10.94%. No significant difference. In vitro antibacterial activity showed that both Gram-positive and -negative bacteria have strong antibacterial activity. 105 patients with enoxacin gluconate for the treatment of acute bacterial infections have a significant effect, the effective rate was 91.4%, the cure rate was 72.38%, the bacterial clearance rate was 88.30% and the incidence of side effects was 8.33%. Respiratory tract, urinary tract infections and other infections have achieved good results.